1. Home
  2. YJ vs ADVB Comparison

YJ vs ADVB Comparison

Compare YJ & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yunji Inc. American Depository Shares

YJ

Yunji Inc. American Depository Shares

N/A

Current Price

$1.44

Market Cap

9.1M

ML Signal

N/A

ADVB

Advanced Biomed Inc.

N/A

Current Price

$5.08

Market Cap

7.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YJ
ADVB
Founded
2015
2014
Country
China
United States
Employees
N/A
31
Industry
Other Specialty Stores
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
7.4M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
YJ
ADVB
Price
$1.44
$5.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.9K
18.2K
Earning Date
03-27-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.26
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$0.19
52 Week High
$2.67
$7.70

Technical Indicators

Market Signals
Indicator
YJ
ADVB
Relative Strength Index (RSI) 42.07 55.38
Support Level $1.41 $3.71
Resistance Level $1.89 $5.59
Average True Range (ATR) 0.07 0.43
MACD -0.01 0.05
Stochastic Oscillator 23.08 78.57

Price Performance

Historical Comparison
YJ
ADVB

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in the PRC.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: